Lipum AB (publ) (STO:LIPUM)
Sweden · Delayed Price · Currency is SEK 13.95
+0.05 (0.36%)
Feb 5, 2026, 4:31 PM CET
Lipum AB Market Cap
Lipum AB has a market cap or net worth of 295.91 million as of February 5, 2026. Its market cap has increased by 1.82% in one year.
Market Cap
295.91M
Enterprise Value
328.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
13.95
Market Cap Chart
Since April 22, 2021, Lipum AB's market cap has increased from 114.77M to 295.91M, an increase of 157.84%. That is a compound annual growth rate of 21.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 294.85M | -4.79% |
| Dec 30, 2025 | 309.70M | 21.67% |
| Dec 30, 2024 | 254.55M | 319.14% |
| Dec 29, 2023 | 60.73M | -43.12% |
| Dec 30, 2022 | 106.78M | 14.23% |
| Dec 30, 2021 | 93.47M | -18.56% |
| Apr 22, 2021 | 114.77M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corline Biomedical AB | 440.55M |
| Mendus AB | 355.16M |
| Ascelia Pharma AB | 352.06M |
| Bio-Works Technologies AB | 296.29M |
| Intervacc AB | 296.17M |
| Elicera Therapeutics AB | 259.67M |
| Xintela AB | 248.91M |
| AlzeCure Pharma AB | 229.25M |